SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech success, 2002
An SI Board Since January 2002
Posts SubjectMarks Bans
117 19 0
Emcee:  Miljenko Zuanic Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
42It is device, but results are intriguing. Thanks to Tech Master. Thursday MarcMiljenko Zuanic-4/1/2002
41Industry shaker news on Medicare You guys also might want to take a look at Titalizard lick-3/31/2002
40Roko, this tread is not for specific stock discussion. I will respond on ABGX trMiljenko Zuanic-3/30/2002
39Miljenko, can you comment/evaluate for me 2 stocks: cra, abgx thanks in advanceRoko Bijac-3/29/2002
38Thursday March 21, 3:30 am Eastern Time Press Release SOURCE: Elan Corporation, Miljenko Zuanic-3/21/2002
37Wednesday March 20, 9:15 am Eastern Time Schering To Acquire Collateral TherapeuMiljenko Zuanic-3/21/2002
36Wednesday March 13, 1:41 pm Eastern Time Press Release SOURCE: Cell TherapeuticsMiljenko Zuanic-3/13/2002
35Monday March 11, 6:19 pm Eastern Time WSJ:SangStat Kidney-Transplant Study Ends Miljenko Zuanic-3/11/2002
34And bad for BGEN (was predictable, but many didn't believed). Related QuoteMiljenko Zuanic-3/8/2002
33Is there future shortage? Thursday March 7, 8:49 am Eastern Time Press Release Miljenko Zuanic-3/7/2002
32Good for CBST! Thursday March 7, 7:49 am Eastern Time Press Release SOURCE: CubMiljenko Zuanic-3/7/2002
31This is sucsess for IMCL, but it is BMY failure. Tuesday March 5, 6:14 pm EasteMiljenko Zuanic-3/5/2002
30Fascinating.... ============= Boston, Feb 27, 2002 (MidnightTrader via COMTEX)scott_jiminez-2/27/2002
29Tuesday February 26, 12:30 pm Eastern Time Press Release SOURCE: Alkermes, Inc. Miljenko Zuanic-2/27/2002
28That Remicade/Enbrel (most notably Enbrel) will be serious competitor to DNA/BGEMiljenko Zuanic-2/23/2002
27Message 17087236 Memantine Ebixa® - approved for treatment of Alzheimers dMiljenko Zuanic-2/20/2002
26Maybe this is still way early, but oportunities are here. Proc. Natl. Acad. SciMiljenko Zuanic-2/19/2002
25Tuesday February 19, 5:51 pm Eastern Time Press Release SOURCE: IDEC PharmaceutMiljenko Zuanic-2/19/2002
24From FDA: Monday February 11, 8:45 am Eastern Time Press Release SOURCE: ScheriMiljenko Zuanic-2/12/2002
23It is more surprise that success, but it deserve to be lead news today. Monday Miljenko Zuanic-2/11/2002
22Message 17037635 Neurosearch,Boehringer Ingelheim In $80M Alzheimer's Deal Miljenko Zuanic-2/8/2002
21Friday February 8, 7:00 am Eastern Time Press Release SOURCE: Texas BiotechnologMiljenko Zuanic-2/8/2002
20Thursday February 7, 9:30 am Eastern Time Press Release SOURCE: Gilead Sciences,Miljenko Zuanic-2/7/2002
19Thanks Michael. It will be base to compare this year bios performance. TuesdayMiljenko Zuanic-2/6/2002
18retrospective - FDA Approvals, 2001 bio.org New Products* Product Company Indimichael_f_murphy-2/5/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News